Improvements in Aerobic Fitness With Exercise Training: the Role of Myokines

Sponsor
University of Stirling (Other)
Overall Status
Recruiting
CT.gov ID
NCT06141512
Collaborator
(none)
24
1
1
19.3
1.2

Study Details

Study Description

Brief Summary

For both healthy adults and patients with cardiovascular disease (CVD), aerobic fitness (V̇O2max) is a stronger predictor of the risk of future chronic disease and premature death than other established risk factors such as hypertension, smoking, or Type 2 diabetes. It is important to improve the understanding of the regulation of V̇O2max to enable optimisation of interventions aimed at increasing V̇O2max in the current predominantly sedentary population. Currently, only exercise training is a viable method for increasing V̇O2max. However, ~10-20% of people who follow fully supervised, standardised training interventions do not demonstrate a measurable increase in V̇O2max. Low response to training is a clinically relevant concern, but the large variability in response to exercise training also provides an opportunity to dissect out the molecular mechanisms responsible for adaptations to V̇O2max by contrasting low vs. high responders to training. It has been previously demonstrated that low responders for VO2max fail to up regulate a number of genes that encode putative 'myokines', while the high responders demonstrated a significant increase in the expression of these genes, suggesting these myokines may play an important mechanistic role in modulating VO2max. The aim of the present study is to examine whether low responders for VO2max have an attenuated increase in the plasma levels of the previously identified myokines.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Reduced-exertion high-intensity interval training (REHIT)
N/A

Detailed Description

For both healthy adults and patients with cardiovascular disease (CVD), aerobic fitness (V̇O2max) is a stronger predictor of the risk of future chronic disease and premature death than other established risk factors such as hypertension, smoking, or Type 2 diabetes. Considering the large medical and economic burden of physical inactivity-related chronic disease it is important to improve the understanding of the regulation of V̇O2max to enable optimisation of interventions aimed at increasing V̇O2max in the current predominantly sedentary population. Furthermore, there is a need to identify novel drug targets to aid pharmacological intervention in those individuals who are unwilling or unable to improve V̇O2max through exercise.

Currently, only exercise training is a viable method for increasing V̇O2max. However, although exercise training on average improves V̇O2max, ~10-20% of people who follow fully supervised, standardised training interventions do not demonstrate a measurable increase in V̇O2max. Low response to training is a clinically relevant concern, but the large variability in response to exercise training also provides an opportunity to dissect out the molecular mechanisms responsible for adaptations to V̇O2max by contrasting low vs. high responders to training.

Using this approach it has previously been shown that in skeletal muscle samples obtained pre- and post- training, 86 genes are differentially regulated in high compared to low responders for V̇O2max. Strikingly, out of these 86 genes, 13 genes encode proteins that have been reported to be released by muscle during or after exercise (i.e., 'messenger proteins' termed myokines). This strongly suggests low responders to exercise training fail to sufficiently upregulate the production and release of these myokines, and that this is (at least partly) the reason why these people do not manage to improve their V̇O2max as much as high responders. However, in order to confirm a mechanistic role of these myokines in increasing V̇O2max, it needs to be demonstrated that beside the change in gene expression, the change in the plasma levels of these myokines is also impaired in low responders for V̇O2max.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
24 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
All participants will undergo the same exercise training intervention. Based on the outcome measure of VO2max, participants will be divided into groups with a low response for VO2max, a medium response, and a high response for VO2max. It will be investigated whether the change in plasma myokine levels differs between the 3 groups.All participants will undergo the same exercise training intervention. Based on the outcome measure of VO2max, participants will be divided into groups with a low response for VO2max, a medium response, and a high response for VO2max. It will be investigated whether the change in plasma myokine levels differs between the 3 groups.
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Improvements in Aerobic Fitness With Exercise Training: the Role of Myokines
Actual Study Start Date :
Oct 23, 2023
Anticipated Primary Completion Date :
Apr 30, 2025
Anticipated Study Completion Date :
Jun 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Reduced-exertion high-intensity interval training (REHIT)

All participants complete 6 weeks (3 sessions/week) of an exercise intervention labelled 'REHIT'. Exercise sessions involve 10 minutes of unloaded cycling interspersed with 2 x 20 sec 'all-out' sprints against a resistance of 7.5% of participant's body weight. Sprints begin at 1:40 min and 5:40 min.

Behavioral: Reduced-exertion high-intensity interval training (REHIT)
Description same as Arm description.
Other Names:
  • Sprint interval training (SIT)
  • Outcome Measures

    Primary Outcome Measures

    1. Training induced changes in VO2max [Pre-intervention and 3 days post-intervention]

      Maximal aerobic capacity (VO2max) will be measured pre- and post-training to determine the change in VO2max.

    2. Training induced changes in plasma myokines [Pre-intervention and 3 days post-intervention]

      Plasma myokine levels of 8 myokines will be measured pre- and post-training to determine the change in plasma myokine levels.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 40 Years
    Sexes Eligible for Study:
    Male
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Male

    • Age ≥ 18 y or <40 y

    • BMI < 35 kg/m2

    • otherwise healthy, untrained individuals

    Exclusion Criteria:
    • Age <18 y or >40 y

    • BMI > 35 kg/m2

    • classification of 'highly physically active' according to the International Physical Activity Questionnaire (IPAQ)

    • answering 'yes' to one or more questions on a standard Physical Activity Readiness Questionnaire (PAR-Q)

    • resting heart rate ≥100bpm, clinically significant hypertension (140/90 mmHg)

    • a personal history of metabolic or cardiovascular disease

    • Female participants because of unknown effects of the menstrual cycle on the levels of the measured myokines.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Stirling Stirling United Kingdom FK9 4LA

    Sponsors and Collaborators

    • University of Stirling

    Investigators

    • Principal Investigator: Niels Vollaard, PhD, University of Stirling

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Niels Vollaard, Principal Investigator, University of Stirling
    ClinicalTrials.gov Identifier:
    NCT06141512
    Other Study ID Numbers:
    • UStirling
    First Posted:
    Nov 21, 2023
    Last Update Posted:
    Nov 27, 2023
    Last Verified:
    Nov 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Niels Vollaard, Principal Investigator, University of Stirling

    Study Results

    No Results Posted as of Nov 27, 2023